You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ABBV-105

Showing 1 - 25 of 320
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rheumatoid Arthritis (RA) Trial in Worldwide (Elsubrutinib, Upadacitinib, Placebo for elsubrutinib)

Terminated
Has Results
  • Rheumatoid Arthritis (RA)
  • Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium
  • +29 more
Aug 18, 2021

Psoriasis Trial in Canada, Japan, United States (Cedirogant, Placebo)

Recruiting
  • Psoriasis
  • Birmingham, Alabama
  • +54 more
Aug 4, 2022

Rheumatoid Arthritis (RA) Trial in Worldwide (Elsubrutinib, Upadacitinib, Placebo for elsubrutinib)

Completed
Has Results
  • Rheumatoid Arthritis (RA)
  • Huntsville, Alabama
  • +114 more
Apr 6, 2021

Systemic Lupus Erythematosus (SLE) Trial in Worldwide (Elsubrutinib, Placebo for Elsubrutinib, Upadacitinib)

Completed
  • Systemic Lupus Erythematosus (SLE)
  • Mesa, Arizona
  • +159 more
Dec 19, 2022

Palmoplantar Pustulosis (PPP) Trial in Japan (Risankizumab, Placebo)

Active, not recruiting
  • Palmoplantar Pustulosis (PPP)
  • Ichinomiya-shi, Aichi, Japan
  • +38 more
Mar 1, 2022

B-cell Lymphoma Trial in Israel, Puerto Rico, Turkey (ABBV-623, ABBV-992)

Terminated
  • B-cell Lymphoma
  • Ramat Gan, Tel-Aviv, Israel
  • +4 more
Feb 2, 2023

Small Cell Lung Cancer Trial in Worldwide (ABBV-011, Budigalimab)

Recruiting
  • Small Cell Lung Cancer
  • Birmingham, Alabama
  • +32 more
Oct 5, 2022

Healthy Volunteers Trial (ABBV-903)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
Oct 5, 2023

Advanced Solid Tumors Cancer Trial in Worldwide (ABBV-927, ABBV-181)

Active, not recruiting
  • Advanced Solid Tumors Cancer
  • Los Angeles, California
  • +21 more
Jan 20, 2023

ABBV-951 Subcutaneous Infusion to Assess Change in Disease

Not yet recruiting
  • Parkinson's Disease (PD)
    • (no location specified)
    Oct 25, 2023

    Acute Myeloid Leukemia Trial (ABBV-787)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Sep 29, 2023

    Subcutaneous Infusion of ABBV-951 to Assess Change in Disease

    Not yet recruiting
    • Parkinson's Disease (PD)
      • (no location specified)
      Jun 15, 2023

      Advanced Solid Tumors Cancer Trial in Worldwide (ABBV-151, Budigalimab)

      Recruiting
      • Advanced Solid Tumors Cancer
      • New Haven, Connecticut
      • +29 more
      Dec 5, 2022

      Healthy Volunteers Trial in Anaheim, Las Vegas (ABBV-552)

      Recruiting
      • Healthy Volunteers
      • Anaheim, California
      • +1 more
      Jan 13, 2023

      ABBV-154 Trial in Grayslake, Las Vegas (ABBV-154 Dose Formulation A, ABBV-154 Dose Formulation B)

      Active, not recruiting
      • ABBV-154
      • ABBV-154 Dose Formulation A
      • ABBV-154 Dose Formulation B
      • Grayslake, Illinois
      • +1 more
      Dec 19, 2022

      Upper Limb Spasticity Trial (ABBV-950, BOTOX, Placebo for ABBV-950)

      Not yet recruiting
      • Upper Limb Spasticity
      • ABBV-950
      • +2 more
      • (no location specified)
      Jul 14, 2023

      Dry Eye Syndrome Trial in Azusa (ABBV-444)

      Recruiting
      • Dry Eye Syndrome
      • Azusa, California
        Canyon City Eyecare /ID# 253652
      May 24, 2023

      Unresectable Metastatic Colorectal Cancer Trial (ABBV-400, Bevacizumab, Folinic Acid)

      Not yet recruiting
      • Unresectable Metastatic Colorectal Cancer
      • (no location specified)
      Oct 25, 2023

      Healthy Trial (ABBV-CLS-7262)

      Not yet recruiting
      • Healthy
      • (no location specified)
      Nov 17, 2023

      Cystic Fibrosis (CF) Trial in Worldwide (Galicaftor, Placebo, Navocaftor)

      Active, not recruiting
      • Cystic Fibrosis (CF)
      • Mobile, Alabama
      • +46 more
      Oct 20, 2022

      DLBCL, Chronic Lymphocytic Leukemia, B Cell Malignancies Trial in Australia, United States (ABBV-525)

      Not yet recruiting
      • Diffuse Large B-Cell Lymphoma
      • +3 more
      • Louisville, Kentucky
      • +6 more
      Nov 14, 2022

      Metastatic Solid Tumors, NSCLC, Melanoma Trial in United States (INBRX-105 - PDL1x41BB antibody, Pembrolizumab)

      Recruiting
      • Metastatic Solid Tumors
      • +7 more
      • Scottsdale, Arizona
      • +12 more
      Jan 26, 2023

      Relapsed/Refractory Multiple Myeloma Trial in Japan (ABBV-383)

      Recruiting
      • Relapsed/Refractory Multiple Myeloma
      • Kashiwa-shi, Chiba, Japan
      • +5 more
      Jan 25, 2023

      Herpes Zoster (HZ), Shingles, Infectious Disease Trial in Hollywood, Tampa, Berlin (JCXH-105, Active Control (Shingrix))

      Recruiting
      • Herpes Zoster (HZ)
      • +2 more
      • JCXH-105
      • Active Control (Shingrix)
      • Hollywood, Florida
      • +2 more
      May 23, 2023

      ALS, Amyotrophic Lateral Sclerosis Trial in Canada, United States (ABBV-CLS-7262, Placebo)

      Active, not recruiting
      • ALS
      • Amyotrophic Lateral Sclerosis
      • Irvine, California
      • +13 more
      Jan 20, 2023